BlockMedx

About:

BlockMedx is the world’s first completely secure, HIPAA-compliant, end-to-end solution for transmitting DEA Controlled Drug prescriptions such as prescription opioid pain relievers and others, from physicians to pharmacies using the Ethereum blockchain. We are offering an EPCS compliant software platform integrated with a drug monitoring program using advanced analytics to detect fraud and abuse and predict patient addiction risk. The application also allows for low-cost medical e-consults anywhere in the world.



Intro:

BlockMedx is a blockchain healthcare infrastructure project focusing on prescription drug fraud, abuse, and non-adherence. BlockMedx is building a next-generation smart e-prescribing and analytics ecosystem that can be used anywhere in the world to send and receive electronic prescriptions, predict patient risk behaviors, and automate micropayment incentives using the token economy to incentivize healthy behavior.



Milestones:

Q1 2017

The idea of BlockMedax is born; Start of conceptual work.

Q2 2017

Development of basic prototype; Outreach to relevant stakeholders and discussion of proposed solution.

Q3 2017

Completion of MVP; BlockMedx network goes live.

Q2 2018

Private sale; MassChallenge Accelerator start.

Q3 2018

Public token sale; Intensive outreach to strategic partners.

Q4 2018

Pilot projects online: targeted areas will be Texas, Kentucky, Ohio and West Virginia; Version 2 Application Upgrades as Protocol Advances.

Q1 2019

Intensify implementations with healthcare systems; Rapid scalling into additional states with the highest opioid death rates; EMR and Telehealth platform API Access and Integration.

Q2 2019

Key partnership with addiction treatment organizations for patient education, communication, and early intervention; Expansion pf network into all prescription drugs with incorporation of communication, education, and early intervention incentive structures.

Q3 2019

Partnerships with payors and healthcare systems to allow discounted payments through patient portal and introduce new value based incentive structure that promotes early prevention rather than treatment.

Q4 2019

ML/AI implementations to automate detection of fraud and abuse in the healthcare system - important to prevent patients from being lost in the system after it is too late; Integration with Pharmaceutical supply chain to prevent counterfeit drugs from entering the market.